FDA News Releases 2 juin 2026 FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
FierceBiotech 2 juin 2026 ASCO: Bristol Myers’ $800M bispecific ADC aces China breast cancer study, putting TROP2 drugs on notice
FierceBiotech 2 juin 2026 ASCO: Celcuity dares to dream of becoming $10B company after breast cancer win over Piqray
FierceBiotech 2 juin 2026 MindMaze Therapeutics culls program, ends legacy ops from Relief merger to cut costs
Novartis 2 juin 2026 ASCO26: Celcuity's drug halves risk of disease progression, death versus Novartis' Piqray in PIK3CA-mutant breast cancer - FirstWord Pharma
Endpoints News 2 juin 2026 #ASCO26: Celcuity plans another FDA filing after positive breast cancer readout